Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR2 | Q8TDS4 | 5/20 | 0.47 |
| ▸ | MGAM | O43451 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | SI | P14410 | 1/20 | 0.36 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.34 |
| ▸ | MEN1 | O00255 | 2/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | CA12 | O43570 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CA7 | P43166 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18824999 | 0.82 | HCAR2 (0.64) | HCAR2ALDH1A1TSHRCYP2C9CA12 | |
| SCHEMBL70685 | 0.82 | — | — | |
| Ammonia Solution, Strong SCHEMBL8823685 | 0.80 | — | — | |
| SCHEMBL6750259 | 0.80 | — | — | |
| SCHEMBL28807956 | 0.80 | MGAM (0.50) | MGAMGAASIMGAM2ALDH1A1 | |
| Hydrochloric Acid SCHEMBL25408509 | 0.80 | — | — | |
| SCHEMBL3370470 | 0.80 | — | — | |
| Urethane SCHEMBL15229306 | 0.79 | ALOX15 (0.54) | HCAR2ALDH1A1KMT2AMEN1TSHR | |
| SCHEMBL28258298 | 0.78 | MGAM (0.44) | MGAMGAASIMGAM2ALDH1A1 | |
| SCHEMBL11063668 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090317483-A1 | Bicomponent Bioadhesive for Biomedical Use | INSTITUTO OFTALMOLOGICO DE ALICANTE, S.L. (ES) | 2009-12-24 | — | — | US | disclosed |
| EP-1825867-A1 | BICOMPONENT BIOADHESIVE FOR BIOMEDICAL USE | Instituto Oftalmologico de Alicante, S.L. (ES) | 2007-08-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090317483-A1 | Bicomponent Bioadhesive for Biomedical Use | PDGFA, PGF, BMP2 | HCAR2 2204/4885MGAM 1160/4885GAA 2948/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.